Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

BACKGROUND: Diabetes is related with increased cancer mortality across multiple cancer types. Its role in lung cancer mortality is still unclear. We aim to determine the prognostic value of fasting plasma glucose (FPG) and diabetes mellitus in patients with locally advanced non-small cell lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergamino, Milana, Rullan, Antonio J., Saigí, Maria, Peiró, Inmaculada, Montanya, Eduard, Palmero, Ramón, Ruffinelli, José Carlos, Navarro, Arturo, Arnaiz, María Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Cardenal, Felipe, Nadal, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385407/
https://www.ncbi.nlm.nih.gov/pubmed/30791870
http://dx.doi.org/10.1186/s12885-019-5370-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385407/
https://www.ncbi.nlm.nih.gov/pubmed/30791870
http://dx.doi.org/10.1186/s12885-019-5370-5

Ejemplares similares